COVID-19 Impact on Vasodilators Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Vasodilators Industry
1.7 COVID-19 Impact: Vasodilators Market Trends
2 Global Vasodilators Quarterly Market Size Analysis
2.1 Vasodilators Business Impact Assessment - COVID-19
2.1.1 Global Vasodilators Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Vasodilators Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Vasodilators Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Vasodilators Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Vasodilators Factory Price by Manufacturers
3.3 Location of Key Manufacturers Vasodilators Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Vasodilators Market
3.5 Key Manufacturers Vasodilators Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Vasodilators Segments, By Type
4.1 Introduction
1.4.1 Arterial Dilators
1.4.2 Venous Dilators
1.4.3 Mixed Dilators
4.2 By Type, Global Vasodilators Market Size, 2019-2021
4.2.1 By Type, Global Vasodilators Market Size by Type, 2020-2021
4.2.2 By Type, Global Vasodilators Price, 2020-2021
5 Impact of Covid-19 on Vasodilators Segments, By Application
5.1 Overview
5.5.1 Hypertension
5.5.2 Angina
5.5.3 Heart Failure
5.2 By Application, Global Vasodilators Market Size, 2019-2021
5.2.1 By Application, Global Vasodilators Market Size by Application, 2019-2021
5.2.2 By Application, Global Vasodilators Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Vasodilators Quarterly Production and Revenue, 2020
7.1.3 Pfizer Vasodilators Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Vasodilators Quarterly Production and Revenue, 2020
7.2.3 Novartis Vasodilators Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Merck
7.3.1 Merck Business Overview
7.3.2 Merck Vasodilators Quarterly Production and Revenue, 2020
7.3.3 Merck Vasodilators Product Introduction
7.3.4 Merck Response to COVID-19 and Related Developments
7.4 Astra Zeneca
7.4.1 Astra Zeneca Business Overview
7.4.2 Astra Zeneca Vasodilators Quarterly Production and Revenue, 2020
7.4.3 Astra Zeneca Vasodilators Product Introduction
7.4.4 Astra Zeneca Response to COVID-19 and Related Developments
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Business Overview
7.5.2 Jhonson and Johnson Vasodilators Quarterly Production and Revenue, 2020
7.5.3 Jhonson and Johnson Vasodilators Product Introduction
7.5.4 Jhonson and Johnson Response to COVID-19 and Related Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Business Overview
7.6.2 Eli Lilly Vasodilators Quarterly Production and Revenue, 2020
7.6.3 Eli Lilly Vasodilators Product Introduction
7.6.4 Eli Lilly Response to COVID-19 and Related Developments
7.7 Sanofi
7.7.1 Sanofi Business Overview
7.7.2 Sanofi Vasodilators Quarterly Production and Revenue, 2020
7.7.3 Sanofi Vasodilators Product Introduction
7.7.4 Sanofi Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Business Overview
7.8.2 Bristol-Myers Squibb Vasodilators Quarterly Production and Revenue, 2020
7.8.3 Bristol-Myers Squibb Vasodilators Product Introduction
7.8.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.9 Bayer
7.9.1 Bayer Business Overview
7.9.2 Bayer Vasodilators Quarterly Production and Revenue, 2020
7.9.3 Bayer Vasodilators Product Introduction
7.9.4 Bayer Response to COVID-19 and Related Developments
7.10 GSK
7.10.1 GSK Business Overview
7.10.2 GSK Vasodilators Quarterly Production and Revenue, 2020
7.10.3 GSK Vasodilators Product Introduction
7.10.4 GSK Response to COVID-19 and Related Developments
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Business Overview
7.11.2 Teva Pharmaceutical Vasodilators Quarterly Production and Revenue, 2020
7.11.3 Teva Pharmaceutical Vasodilators Product Introduction
7.11.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Vasodilators Supply Chain Analysis
8.1.1 Vasodilators Supply Chain Analysis
8.1.2 Covid-19 Impact on Vasodilators Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Vasodilators Distribution Channels
8.2.2 Covid-19 Impact on Vasodilators Distribution Channels
8.2.3 Vasodilators Distributors
8.3 Vasodilators Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Vasodilators Assessment
Table 9. COVID-19 Impact: Vasodilators Market Trends
Table 10. COVID-19 Impact Global Vasodilators Market Size
Table 11. Global Vasodilators Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Vasodilators Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Vasodilators Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Vasodilators Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Vasodilators Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Vasodilators Market Growth Drivers
Table 17. Global Vasodilators Market Restraints
Table 18. Global Vasodilators Market Opportunities
Table 19. Global Vasodilators Market Challenges
Table 20. Key Manufacturers Vasodilators Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Vasodilators Market Size, 2019 (K Units) & (US$ Million)
Table 22. Vasodilators Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Vasodilators Manufacturing Plants
Table 24. Key Manufacturers Vasodilators Market Served
Table 25. Date of Key Manufacturers Enter into Vasodilators Market
Table 26. Key Manufacturers Vasodilators Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Vasodilators Market Size by Type, 2020, (US$ Million)
Table 29. Global Vasodilators Market Size by Type, 2020 (K Units)
Table 30. Global Vasodilators Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Vasodilators Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Vasodilators Market Size by Application, 2020-2021 (K Units)
Table 33. Global Vasodilators Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Vasodilators Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Vasodilators Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Vasodilators Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Vasodilators Market Size, 2019-2021 (K Units)
Table 38. US Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Vasodilators Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Vasodilators Market Size, 2019-2021 (K Units)
Table 43. Germany Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Vasodilators Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Vasodilators Market Size, 2019-2021 (K Units)
Table 50. China Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Vasodilators Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Pfizer Business Overview
Table 58. Pfizer Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer Vasodilators Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Vasodilators Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Merck Business Overview
Table 66. Merck Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck Vasodilators Product
Table 68. Merck Response to COVID-19 and Related Developments
Table 69. Astra Zeneca Business Overview
Table 70. Astra Zeneca Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Astra Zeneca Vasodilators Product
Table 72. Astra Zeneca Response to COVID-19 and Related Developments
Table 73. Jhonson and Johnson Business Overview
Table 74. Jhonson and Johnson Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Jhonson and Johnson Vasodilators Product
Table 76. Jhonson and Johnson Response to COVID-19 and Related Developments
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Eli Lilly Vasodilators Product
Table 80. Eli Lilly Response to COVID-19 and Related Developments
Table 81. Sanofi Business Overview
Table 82. Sanofi Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Sanofi Vasodilators Product
Table 84. Sanofi Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb Vasodilators Product
Table 88. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 89. Bayer Business Overview
Table 90. Bayer Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bayer Vasodilators Product
Table 92. Bayer Response to COVID-19 and Related Developments
Table 93. GSK Business Overview
Table 94. GSK Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. GSK Vasodilators Product
Table 96. GSK Response to COVID-19 and Related Developments
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Vasodilators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Teva Pharmaceutical Vasodilators Product
Table 100. Teva Pharmaceutical Response to COVID-19 and Related Developments
Table 101. Vasodilators Distributors List
Table 102. Vasodilators Customers List
Table 103. Covid-19 Impact on Vasodilators Customers
List of FiguresFigure 1. Vasodilators Product Picture
Figure 2. Vasodilators Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Vasodilators Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Vasodilators Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Vasodilators Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Vasodilators Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Vasodilators Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Vasodilators Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Vasodilators Market Size Market Share, 2019-2021